SCHEMBL12240239

SCHEMBL12240239

O=C(c1cc(F)ccc1CF)N1CCNCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 6/20 0.50
RXFP1 Q9HBX9 1/20 0.46
TDO2 P48775 1/20 0.44
HSP90AA1 P07900 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
HTR2C P28335 2/20 0.42
HTR2A P28223 1/20 0.42
MAPK14 Q16539 2/20 0.41
CHEK1 O14757 1/20 0.41
AURKA O14965 1/20 0.41
DAPK3 O43293 1/20 0.41
JAK2 O60674 1/20 0.41
PRKD3 O94806 1/20 0.41
PAK4 O96013 1/20 0.41
ABL1 P00519 1/20 0.41
NTRK1 P04629 1/20 0.41
LCK P06239 1/20 0.41
FYN P06241 1/20 0.41
CSF1R P07333 1/20 0.41
RET P07949 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3087941 0.82 PARP1 (0.63) PARP1RXFP1TDO2HSP90AA1SIGMAR1
SCHEMBL31220894 0.82 PARP1 (0.63) PARP1RXFP1TDO2HSP90AA1SIGMAR1
SCHEMBL12240067 0.81 RXFP1 (0.60) PARP1RXFP1HSP90AA1SIGMAR1HRH4
SCHEMBL1223521 0.79 PARP1 (0.49) PARP1RXFP1TDO2HSP90AA1SIGMAR1
Hydrochloric Acid SCHEMBL2849329 0.78 KDM4E (0.58) PARP1RXFP1TDO2HSP90AA1SIGMAR1
SCHEMBL938535 0.77 HCRTR1 (0.50) PARP1RXFP1TDO2HSP90AA1SIGMAR1
SCHEMBL31568105 0.77 RXFP1 (0.63) PARP1RXFP1HSP90AA1ALDH1A1HPGD
Hydrochloric Acid SCHEMBL224268 0.76 HCRTR1 (0.49) PARP1RXFP1TDO2HSP90AA1SIGMAR1
Hydrochloric Acid SCHEMBL20524495 0.75 PARP1 (0.48) PARP1RXFP1TDO2HSP90AA1SIGMAR1
SCHEMBL937498 0.74 GPR183 (0.50) PARP1RXFP1TDO2HSP90AA1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8039463-B2 Piperazine derivatives as inhibitors of stearoyl-CoA desaturase FOREST LABORATORIES HOLDINGS LIMITED (BM) 2011-10-18 US disclosed
US-20090239848-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239848-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE SCD, SCD5, FADS2 PARP1 1257/4885RXFP1 4083/4885TDO2 1852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.